CRESCENT BIOPHARMA INC (CBIO) Stock Income Statement
NASDAQ:CBIO • KYG2545C1042
Current stock price
19.11 USD
+0.79 (+4.31%)
Last:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 10.84M | 0.00 | 10.00K | 80.00K | 1.16M | |||
| Cost Of Goods | N/A | N/A | N/A | 798.00K | 7.38M | |||
| Gross Profit | N/A | N/A | N/A | -4.00K | -42.00K | |||
| Operating Expenses | 156.27M | 32.51M | 39.29M | 47.48M | 64.61M | |||
| Research and Development | 145.97M | 14.26M | 20.07M | 28.39M | 47.49M | |||
| Selling, General, and Administrative Expenses | 10.30M | 18.25M | 19.21M | 19.09M | 17.12M | |||
| Operating Income | -145.43M | -32.51M | -39.28M | -47.40M | -63.45M | |||
| Interest Income/Expense | 690.00K | 935.30K | 2.38M | 710.00K | 20.00K | |||
| Other Income/Expense | N/A | N/A | N/A | 0.00 | -78.00K | |||
| Non Recurring Items | -7.21M | -7.53M | N/A | 20.98M | N/A | |||
| Income Before Taxes | -151.94M | -37.88M | -36.90M | -46.69M | -63.43M | |||
| Income Tax | 4.00M | N/A | N/A | 348.00K | N/A | |||
| Net Income | -155.94M | -37.88M | -36.90M | -46.69M | -63.43M | |||
| EBITDA | -145.34M | -32.47M | -39.12M | -47.19M | -63.19M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -14.97 | -58.75 | -58.25 | -0.89 | -1.23 | |||
| Non GAAP EPS | -10.74 | N/A | -58.00 | -88.00 | -123.00 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | -5.00% | -3.62% | |||
| Profit Margin | -1438.05% | N/A | -368994.00% | -58362.50% | -5468.10% | |||
| Operating Profit Margin | -1341.07% | N/A | -392753.00% | -59250.00% | -5469.83% | |||
All data in USD